A new painkiller due to be released onto the market within days has seen lawmakers and doctors alike warning of its ability to kill with just TWO TABLETS being taken.
Although approved by the FDA, the agency’s own advisory panel was against licencing the drug, voting 11-2 against approval. Coming in different strengths ZOHYRDO is between five and ten times stronger than its nearest equivalent,Vicodin.
Doctors are warning that just two capsules has the potential to kill people who are susceptible to the opiate. Speaking to Forbes, Andrew Kolodny, of the advocacy group Physicians for Responsible Opioid Prescribing, was blunt and direct:
“It’s a whopping dose of hydrocodone packed in an easy-to-crush capsule. It will kill people as soon as it’s released.”
According to NBC News, Congressional representatives and attorney generals from 28 states have also called on the FDA to reconsider the drug’s approval.
Opponents to the drugs approval argue that those patients with a susceptibility to the opiate, something which may not be known by either the patient or their doctor, will be putting their lives in danger, even by taking just one or two of the capsules. As they are so much stronger than their nearest counterpart there is just no way of knowing what a persons reaction to the drug will be.
Although Zohydro is comprised of the same ingredients found in Vicodin and OxyContin, but it’s not just the higher dose that has medical experts and lawmakers concerned. The FDA did not mandate Zohydro to follow the same abuse-deterrents that other drugs do.
Abuse deterrents are built into drugs so that they don’t work nearly as effectively if they are taken any other way, but the way prescribed.
This is not the case with Zohydro, the drug will remain just as effective if crushed, snorted, or taken in a way other than originally intended. All this has opponents worried that Zohydro’s potential for abuse greatly exceeds that of other options on the market.
In a letter to the FDA more than 40 doctors urged the FDA to reconsider it’s actions and reverse their approval of the drug.
So far the FDA have made no comment.
Delivered by The Daily Sheeple
We encourage you to share and republish our reports, analyses, breaking news and videos (Click for details).
Contributed by Lizzie Bennett of Underground Medic.
Lizzie Bennett retired from her job as a senior operating department practitioner in the UK earlier this year. Her field was trauma and accident and emergency and she has served on major catastrophe teams around the UK. Lizzie publishes Underground Medic on the topic of preparedness.